accumulated to indicate that self-referral can be associated with overuse of both diagnostic procedures and therapeutic interventions." Finally, angioplasty may be fun to perform. Introducing a wire into a tortuous coronary artery while planning the turns to make on a fluoroscopic screen generates challenge and excitement similar to those of the latest videogame. We have suggested previously that the synergistic effects of the combination of these three factors may have markedly contributed to the unprecedented explosive growth of this new medical procedure despite obvious limitations and unresolved issues.10 We speculated that "faced with an accessible coronary lesion, an interventionist's decision about whether to intervene is most often predictable, and does not rely on a thorough, objective, and independent review of the appropriateness of the procedure in the particular clinical context. "10 In this issue of Circulation, Topol et al12 now substantiate this prediction by showing that in a large insured patient population, angioplasty was performed without exercise testing to document the presence of ischemia in a large majority of the patients. Indeed, in their population of 2,101 patients, only 29% had undergone an exercise test before their coronary angioplasty, a practice that stands in contrast with guidelines established by the two major professional organizations that recommend preprocedural demonstration of myocardial ischemia. 13 Furthermore, in the subgroup of patients having undergone angioplasty after thrombolytic therapy for acute myocardial infarction, only 9% had an exercise test before angioplasty. This finding is at odds with several recent trials indicating that an angioplasty is not needed if such patients have a negative exercise test. Thus, the study by Topol et al12 suggests that angioplasty is performed primarily on the basis of coronary anatomic findings. This interpretation is in accordance with findings in patients after myocardial infarction.14 In that study, patients at low risk of cardiac mortality according to clinical criteria often underwent coronary angiography in the absence of prior exercise testing. After angiography, many such patients had revascularization procedures, including angioplasty and coronary bypass surgery, suggesting again that coronary anatomy rather than clinical evaluation and evidence of ischemia guided the therapeutic approach. '4 Angioplasty clearly has become a useful and safe procedure for the effective treatment of symptomatic ischemia in subsets of patients with coronary artery disease. Its growth has triggered the development of additional new technology in the field of interventional cardiology that, in the future, may allow treatment of patients with more complex forms of coronary disease with acceptable morbidity and mortality. If the results of ongoing studies show that long-term mortality, particularly in patients with multivessel coronary artery disease, is altered by angioplasty and compares favorably with results of bypass surgery, angioplasty may become a cost-effective treatment for a large number of patients with coronary disease. One might also expect that when the indications for angioplasty are better defined on the basis of multicentric randomized studies, greater procedural uniformity across the country will ensue. In the meantime, cardiologists should consider restricting the use of angioplasty for symptomatic relief of coronary artery disease in accordance with the guidelines established by their professional associations. It should also be remembered that medical treatment is effective in a large number of patients with single-vessel and even multivessel coronary artery disease,15 and it may avoid the costs, immediate risks, and morbidity of angioplasty. Finally, research efforts on regression of atherosclerosis and reduction of the risk of plaque rupture and thrombosis should be pursued. Preliminary data, for instance, suggest that cholesterol reduction might be as effective as mechanical interventions in reducing morbidity from coronary artery disease. 16-'8 Given the budget constraints, incentives may be needed that will enable physicians to use health care resources in the most appropriate and cost-effective way. In the case of angioplasty, which costs the health care system billions of dollars, restricting its current use to accepted medical indications seems imperative to avoid bankruptcy of the system and to allow the development of other aspects of interventional cardiology and of modern technology for the benefit of the overall population.
